Cargando…
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927997/ https://www.ncbi.nlm.nih.gov/pubmed/32381571 http://dx.doi.org/10.3324/haematol.2019.224535 |
| _version_ | 1783659772837363712 |
|---|---|
| author | Morschhauser, Franck Bouabdallah, Kamal Stilgenbauer, Stephan Thieblemont, Catherine de Guibert, Sophie Zettl, Florian Gelbert, Lawrence M. Turner, P. Kellie Kambhampati, Siva Rama Prasad Li, Li Li, Lily Q. Buchanan, Sean Barriga, Susana Bear, Melissa M. Wilhelm, Martin Hess, Georg |
| author_facet | Morschhauser, Franck Bouabdallah, Kamal Stilgenbauer, Stephan Thieblemont, Catherine de Guibert, Sophie Zettl, Florian Gelbert, Lawrence M. Turner, P. Kellie Kambhampati, Siva Rama Prasad Li, Li Li, Lily Q. Buchanan, Sean Barriga, Susana Bear, Melissa M. Wilhelm, Martin Hess, Georg |
| author_sort | Morschhauser, Franck |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7927997 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79279972021-03-05 Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study Morschhauser, Franck Bouabdallah, Kamal Stilgenbauer, Stephan Thieblemont, Catherine de Guibert, Sophie Zettl, Florian Gelbert, Lawrence M. Turner, P. Kellie Kambhampati, Siva Rama Prasad Li, Li Li, Lily Q. Buchanan, Sean Barriga, Susana Bear, Melissa M. Wilhelm, Martin Hess, Georg Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-05-07 /pmc/articles/PMC7927997/ /pubmed/32381571 http://dx.doi.org/10.3324/haematol.2019.224535 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Morschhauser, Franck Bouabdallah, Kamal Stilgenbauer, Stephan Thieblemont, Catherine de Guibert, Sophie Zettl, Florian Gelbert, Lawrence M. Turner, P. Kellie Kambhampati, Siva Rama Prasad Li, Li Li, Lily Q. Buchanan, Sean Barriga, Susana Bear, Melissa M. Wilhelm, Martin Hess, Georg Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title | Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title_full | Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title_fullStr | Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title_full_unstemmed | Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title_short | Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase II study |
| title_sort | clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma – a phase ii study |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927997/ https://www.ncbi.nlm.nih.gov/pubmed/32381571 http://dx.doi.org/10.3324/haematol.2019.224535 |
| work_keys_str_mv | AT morschhauserfranck clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT bouabdallahkamal clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT stilgenbauerstephan clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT thieblemontcatherine clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT deguibertsophie clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT zettlflorian clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT gelbertlawrencem clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT turnerpkellie clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT kambhampatisivaramaprasad clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT lili clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT lililyq clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT buchanansean clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT barrigasusana clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT bearmelissam clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT wilhelmmartin clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy AT hessgeorg clinicalactivityofabemaciclibinpatientswithrelapsedorrefractorymantlecelllymphomaaphaseiistudy |